Your browser doesn't support javascript.
loading
Incidence and clinical outcomes of perforations during mechanical thrombectomy for medium vessel occlusion in acute ischemic stroke: A retrospective, multicenter, and multinational study.
Dmytriw, Adam A; Musmar, Basel; Salim, Hamza; Ghozy, Sherief; Siegler, James E; Kobeissi, Hassan; Shaikh, Hamza; Khalife, Jane; Abdalkader, Mohamad; Klein, Piers; Nguyen, Thanh N; Heit, Jeremy J; Regenhardt, Robert W; Cancelliere, Nicole M; Bernstock, Joshua D; Naamani, Kareem El; Amllay, Abdelaziz; Meyer, Lukas; Dusart, Anne; Bellante, Flavio; Forestier, Géraud; Rouchaud, Aymeric; Saleme, Suzana; Mounayer, Charbel; Fiehler, Jens; Kühn, Anna Luisa; Puri, Ajit S; Dyzmann, Christian; Kan, Peter T; Colasurdo, Marco; Marnat, Gaultier; Berge, Jérôme; Barreau, Xavier; Sibon, Igor; Nedelcu, Simona; Henninger, Nils; Marotta, Thomas R; Stapleton, Christopher J; Rabinov, James D; Ota, Takahiro; Dofuku, Shogo; Yeo, Leonard Ll; Tan, Benjamin Yq; Gopinathan, Anil; Martinez-Gutierrez, Juan Carlos; Salazar-Marioni, Sergio; Sheth, Sunil; Renieri, Leonardo; Capirossi, Carolina; Mowla, Ashkan.
Afiliación
  • Dmytriw AA; Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Musmar B; Neurovascular Centre, Divisions of Therapeutic Neuroradiology and Neurosurgery, St. Michael's Hospital, University of Toronto, ON, Canada.
  • Salim H; Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Shreveport, LA, USA.
  • Ghozy S; Department of Radiology, Division of Neuroradiology, Johns Hopkins Medical Center, Baltimore, MD, USA.
  • Siegler JE; Department of Neurological Surgery and Radiology, Mayo Clinic, Rochester, MN, USA.
  • Kobeissi H; Cooper Neurological Institute, Cooper University Hospital, Cooper Medical School of Rowen University, Camden, NJ, USA.
  • Shaikh H; Department of Neurological Surgery and Radiology, Mayo Clinic, Rochester, MN, USA.
  • Khalife J; Cooper Neurological Institute, Cooper University Hospital, Cooper Medical School of Rowen University, Camden, NJ, USA.
  • Abdalkader M; Cooper Neurological Institute, Cooper University Hospital, Cooper Medical School of Rowen University, Camden, NJ, USA.
  • Klein P; Departments of Radiology and Neurology, Boston Medical Center, Boston, MA, USA.
  • Nguyen TN; Departments of Radiology and Neurology, Boston Medical Center, Boston, MA, USA.
  • Heit JJ; Departments of Radiology and Neurology, Boston Medical Center, Boston, MA, USA.
  • Regenhardt RW; Department of Interventional Neuroradiology, Stanford Medical Center, Palo Alto, CA, USA.
  • Cancelliere NM; Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Bernstock JD; Neurovascular Centre, Divisions of Therapeutic Neuroradiology and Neurosurgery, St. Michael's Hospital, University of Toronto, ON, Canada.
  • Naamani KE; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.
  • Amllay A; Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Meyer L; Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Dusart A; Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bellante F; Department of Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium.
  • Forestier G; Department of Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium.
  • Rouchaud A; University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.
  • Saleme S; University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.
  • Mounayer C; University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.
  • Fiehler J; University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.
  • Kühn AL; Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Puri AS; Division of Neurointerventional Radiology, Department of Radiology, University of Massachusetts Medical Center, Worcester, MA, USA.
  • Dyzmann C; Division of Neurointerventional Radiology, Department of Radiology, University of Massachusetts Medical Center, Worcester, MA, USA.
  • Kan PT; Neuroradiology Department, Sana Kliniken, Lübeck GmbH, Lübeck, Germany.
  • Colasurdo M; Department of Neurosurgery, University of Texas Medical Branch, Galveston, TX, USA.
  • Marnat G; Department of Neurosurgery, University of Texas Medical Branch, Galveston, TX, USA.
  • Berge J; Department of Interventional Radiology, Oregon Health and Science University, Portland, OR, USA.
  • Barreau X; Interventional Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France.
  • Sibon I; Interventional Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France.
  • Nedelcu S; Interventional Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France.
  • Henninger N; Neurology Department, Bordeaux University Hospital, Bordeaux, France.
  • Marotta TR; Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Stapleton CJ; Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Rabinov JD; Department of Psychiatry, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Ota T; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Dofuku S; Neurovascular Centre, Divisions of Therapeutic Neuroradiology and Neurosurgery, St. Michael's Hospital, University of Toronto, ON, Canada.
  • Yeo LL; Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Tan BY; Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Gopinathan A; Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan.
  • Martinez-Gutierrez JC; Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan.
  • Salazar-Marioni S; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Sheth S; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Renieri L; Division of Neurology, Department of Medicine, National University Hospital, Singapore, Singapore.
  • Capirossi C; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Mowla A; Division of Neurology, Department of Medicine, National University Hospital, Singapore, Singapore.
Eur Stroke J ; 9(2): 328-337, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38409796
ABSTRACT

BACKGROUND:

Mechanical thrombectomy (MT) has revolutionized the treatment of acute ischemic stroke (AIS) due to large vessel occlusion (LVO), but its efficacy and safety in medium vessel occlusion (MeVO) remain less explored. This multicenter, retrospective study aims to investigate the incidence and clinical outcomes of vessel perforations (confirmed by extravasation during an angiographic series) during MT for AIS caused by MeVO.

METHODS:

Data were collected from 37 academic centers across North America, Asia, and Europe between September 2017 and July 2021. A total of 1373 AIS patients with MeVO underwent MT. Baseline characteristics, procedural details, and clinical outcomes were analyzed.

RESULTS:

The incidence of vessel perforation was 4.8% (66/1373). Notably, our analysis indicates variations in perforation rates across different arterial segments 8.9% in M3 segments, 4.3% in M2 segments, and 8.3% in A2 segments (p = 0.612). Patients with perforation had significantly worse outcomes, with lower rates of favorable angiographic outcomes (TICI 2c-3 23% vs 58.9%, p < 0.001; TICI 2b-3 56.5% vs 88.3%, p < 0.001). Functional outcomes were also worse in the perforation group (mRS 0-1 at 3 months 22.7% vs 36.6%, p = 0.031; mRS 0-2 at 3 months 28.8% vs 53.9%, p < 0.001). Mortality was higher in the perforation group (30.3% vs 16.8%, p = 0.008).

CONCLUSION:

This study reveals that while the occurrence of vessel perforation in MT for AIS due to MeVO is relatively rare, it is associated with poor functional outcomes and higher mortality. The findings highlight the need for increased caution and specialized training in performing MT for MeVO. Further prospective research is required for risk mitigation strategies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cerebrovascular_disease Asunto principal: Trombectomía / Accidente Cerebrovascular Isquémico Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Stroke J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cerebrovascular_disease Asunto principal: Trombectomía / Accidente Cerebrovascular Isquémico Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Stroke J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
...